BPC-157 vs TB-500: A Research Comparison
Two of the most studied peptides in tissue and cell-migration research — compared as laboratory reference compounds.
BPC-157 and TB-500 are two of the most frequently studied peptides in tissue, vascular and cell-migration research — and they are often mentioned together. But they are structurally and mechanistically distinct compounds with different research origins. This guide compares them purely as laboratory reference compounds: what each one is, the pathways researchers study, and why the two are often examined side by side.
At a glance
| BPC-157 | TB-500 | |
|---|---|---|
| Class | Synthetic pentadecapeptide (15 amino acids) | Synthetic fragment of thymosin beta-4 |
| Studied for | Angiogenesis, growth-factor signalling, connective-tissue models | Actin regulation, cell migration, tissue-model systems |
| Research area | Tissue & recovery research | Tissue & recovery research |
| Format | Lyophilised powder, 10mg vial | Lyophilised powder, 10mg vial |
| Supplied for | In-vitro / laboratory research only | |
What each compound is
BPC-157 is a synthetic pentadecapeptide whose sequence corresponds to a fragment associated with a gastric protein. In published in-vitro and animal-model literature it is investigated in the context of angiogenesis (the formation of new blood vessels), growth-factor signalling pathways and connective-tissue models.
TB-500 is a synthetic peptide corresponding to an active region of thymosin beta-4, a naturally occurring protein. Research literature examines it primarily in relation to actin regulation — actin being a key structural protein in cells — and the cell-migration processes that depend on it.
How they differ in research
The key distinction is the mechanism each is used to study. BPC-157 research tends to focus on vascular and growth-factor pathways, whereas TB-500 research centres on the cytoskeletal (actin) processes underlying cell movement. Because both are studied in overlapping tissue-model and cell-migration contexts, researchers frequently examine them together to compare or combine these different mechanisms — which is why the two are commonly paired.
Why they are often studied together
Since the two compounds are investigated through complementary mechanisms within the same broad research area, they are often referenced and sourced together. For that reason Helix offers them as a combined research bundle at a reduced price, supplied as two separate lyophilised vials.
Storage & handling
Both are supplied as lyophilised (freeze-dried) powders. General laboratory practice is to store the lyophilised material at -20°C away from light and moisture, and to refrigerate any reconstituted solution at 2–8°C, protected from repeated freeze-thaw cycles and handled according to your laboratory's standard operating procedures.
Why third-party testing matters most
The research-peptide market is unregulated, so the single most useful quality check is an independent, per-batch certificate of analysis (COA). A genuine third-party report (for example from Janoshik) shows the measured purity and a batch number you can verify against the vial. Helix publishes lab reports on the product pages wherever testing has been completed.
View the research listings
All three are supplied as lyophilised powder for laboratory research only, with batch references.
BPC-157 (research)TB-500 (research)Recovery bundleFrequently asked questions
What is the main difference between BPC-157 and TB-500?
BPC-157 is a synthetic pentadecapeptide studied for angiogenesis and growth-factor pathways; TB-500 is a thymosin beta-4 fragment studied for actin regulation and cell migration. They are distinct compounds investigated through complementary mechanisms.
Why are BPC-157 and TB-500 often bought together?
Because they are studied through complementary mechanisms within the same tissue and recovery research area, they are frequently examined side by side, which is why they are commonly sourced together as a research bundle.
Are they legal to buy in the UK?
Research peptides can be supplied in the UK for laboratory research only, provided they are clearly labelled as such and carry no medical claims. They are not authorised for human or veterinary use.
How should they be stored?
As a lyophilised powder, generally at -20°C away from light and moisture; reconstituted solution refrigerated at 2–8°C and handled per laboratory SOP.
How do I verify purity?
Ask for the independent, batch-specific COA and check the purity percentage and batch number against the vial.